Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression
暂无分享,去创建一个
C. Rossi | A. Migheli | C. Bendotti | A. Botturi | P. Veglianese | P. Veglianese | A. Giorgini | M Tortarolo | P Veglianese | N Calvaresi | A Botturi | C Rossi | A Giorgini | A Migheli | C Bendotti | M. Tortarolo | N. Calvaresi | C. Rossi
[1] Makoto Urushitani, Shun Shimohama. The role of nitric oxide in amyotrophic lateral sclerosis , 2001, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[2] B. Fiebich,et al. Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia , 2001, The Journal of Neuroscience.
[3] P. Mcgeer,et al. Inflammatory processes in amyotrophic lateral sclerosis , 2002, Muscle & nerve.
[4] K. Heidenreich,et al. Apoptosis Induced by Withdrawal of Trophic Factors Is Mediated by p38 Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.
[5] W. Lesslauer,et al. Blockade of p38 Mitogen-activated Protein Kinase Pathway Inhibits Inducible Nitric-oxide Synthase Expression in Mouse Astrocytes* , 1997, The Journal of Biological Chemistry.
[6] J. Trojanowski,et al. Neurofilaments and Orthograde Transport Are Reduced in Ventral Root Axons of Transgenic Mice that Express Human SOD1 with a G93A Mutation , 1997, The Journal of cell biology.
[7] W. Robberecht,et al. Minocycline delays disease onset and mortality in a transgenic model of ALS , 2002, Neuroreport.
[8] D. Schiffer,et al. Lack of apoptosis in mice with ALS , 1999, Nature Medicine.
[9] K. Mielke,et al. JNK and p38 stresskinases — degenerative effectors of signal-transduction-cascades in the nervous system , 2000, Progress in Neurobiology.
[10] D. Cleveland,et al. Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neurons , 1999 .
[11] Guy A. Rouleau,et al. SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .
[12] J. Powell,et al. Mutations in all five exons of SOD‐1 may cause ALS , 1998, Annals of neurology.
[13] G. Borasio,et al. Inhibitors of p38 mitogen‐activated protein kinase promote neuronal survival in vitro , 1998, Journal of neuroscience research.
[14] J. Trojanowski,et al. Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits , 1995, The Journal of cell biology.
[15] George Perry,et al. Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease , 2000 .
[16] M. Gurney,et al. Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation , 1997, Annals of neurology.
[17] Y. B. Lee,et al. p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. , 2000, Cytokine.
[18] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[19] V. Silani,et al. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity , 2001, Journal of the Neurological Sciences.
[20] J. Rothstein,et al. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.
[21] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[22] J. Rothstein. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. , 1995, Clinical neuroscience.
[23] C. Shaw,et al. Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons , 2000, The Journal of cell biology.
[24] Robert H. Brown,et al. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter , 1999, Nature Neuroscience.
[25] M. Gurney,et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] Betty Y. S. Kim,et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice , 2002, Nature.
[27] S. Appel,et al. Immune reactivity in a mouse model of familial ALS correlates with disease progression , 2001, Neurology.
[28] G. Sobue,et al. Differential expression of inflammation‐ and apoptosis‐related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[29] P. Leigh,et al. Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[30] M. Carson,et al. ALS, SOD and peroxynitrite , 1993, Nature.
[31] D. Schiffer,et al. Ubiquitin and neurofilament expression in anterior horn cells in amyotrophic lateral sclerosis: possible clues to the pathogenesis , 1994, Neuropathology and applied neurobiology.
[32] S. Skaper,et al. Neurotrophic Molecules: Strategies for Designing Effective Therapeutic Molecules in Neurodegeneration , 1998, Molecular and Cellular Neuroscience.
[33] M. Rattray,et al. Transgenic SOD1 G93A mice develop reduced GLT‐1 in spinal cord without alterations in cerebrospinal fluid glutamate levels , 2001, Journal of neurochemistry.
[34] S. Snyder,et al. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. , 1994, Science.
[35] J. Julien,et al. Amyotrophic Lateral Sclerosis Unfolding the Toxicity of the Misfolded , 2001, Cell.
[36] A. Grierson,et al. Axonal transport of neurofilaments in normal and disease states , 2002, Cellular and Molecular Life Sciences CMLS.
[37] B. Ghetti,et al. Activation of the JNK/p38 Pathway Occurs in Diseases Characterized by Tau Protein Pathology and Is Related to Tau Phosphorylation But Not to Apoptosis , 2001, Journal of neuropathology and experimental neurology.
[38] I. Ferrer,et al. Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat. , 2001, Brain research. Molecular brain research.
[39] Jeffrey D. Rothstein,et al. From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.
[40] Jiahuai Han,et al. The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.
[41] J. Julien,et al. Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis , 2002, Neurobiology of Disease.